I am drinking it twice in the morning and evening
doi: 10.1038/s41598-019-50044-z 69 ZhangQItagakiKHauserCJ
Its mechanism of action positions it as a promising senolytic therapy with potential applications in treating age-related diseases and improving overall health
Subgroup analyses showed that compared to sitagliptin, the exenatide group had a significant reduction in total cholesterol (0.16 mmol/L, 0.29 to 0.03, I 2 = 0%, P = 0.34) and no significant increase in HDL cholesterol (0.02 mmol/L, 0.05 to 0.02, I 2 = 0%, P = 0.68)
Nature PubMed Preclinical literature and narrative reviews describe pleiotropic actions including angiogenesis modulation (promotion in healing contexts and proposed inhibition in rodent corneal neovascularization models) and purported cytoprotective effects across diverse injury paradigms, but these remain unconfirmed in controlled human experiments